You are here

sasanlimab

Pfizer’s sasanlimab and BCG combo therapy improves EFS in bladder cancer trial

Clinical Trials Arena

Mon, 04/28/25 - 09:39 am

clinical trials

non-muscle invasive bladder cancer

Pfizer’s Phase III bladder cancer therapy trial meets primary endpoint

Clinical Trials Arena

Mon, 01/13/25 - 11:10 am

clinical trials

Pfizer reveals its PD-1 secret

EP Vantage

Fri, 02/5/21 - 10:42 am